The use of unlicensed bone marrow–derived platelet lysate–expanded mesenchymal stromal cells in colitis: a pre-clinical study

This publication has 72 references indexed in Scilit:

• Mesenchymal Stem Cells (MSC) Prevented the Progression of Renovascular Hypertension, Improved Renal Function and Architecture
  PLOS ONE, 2013
• Expression of Angiotensin II Receptor-1 in Human Articular Chondrocytes
  Arthritis, 2012
• Intraperitoneal but Not Intravenous Cryopreserved Mesenchymal Stromal Cells Home to the Inflamed Colon and Ameliorate Experimental Colitis
  PLOS ONE, 2012
• Use of Enterally Delivered Angiotensin II Type Ia Receptor Antagonists to Reduce the Severity of Colitis
  Digestive Diseases and Sciences, 2011
• Mesenchymal stem cell therapy: Two steps forward, one step back
  Trends in Molecular Medicine, 2010
• Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil
  BMC Gastroenterology, 2010
• Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect
  Stem Cells and Development, 2009
• Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment
  Surgery, 2008
• An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis
  Regulatory Peptides, 2007
• Reduced Severity of a Mouse Colitis Model with Angiotensin Converting Enzyme Inhibition
  Digestive Diseases and Sciences, 2007